AT
Atara Biotherapeutics, Inc.
ATRA · NASDAQ
$8.93 -5.25% (-$0.50)
1M -0.85%
Market Cap $87.5M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$12.46
39.5% upside
Trenutna cena
$8.93
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ATRA trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 14.12x
EV/EBITDA N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 23.85%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 269.42%
Op. margin 229.67%
FCF margin 353.49%
Quality
5 /100
Poor ROA 79.38%
Asset turnover 0.29x
ROIC 93.30%
Debt
42 /100
Moderate Int. coverage -4.90x
Current ratio 1.98x
Net debt/EBITDA N/A
Stability
6 /100
Unstable Rev. volatility 838.38%
EPS volatility 71.55%
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ATRA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Anhco Nguyen
Employees
10
Headquarters
Thousand Oaks
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report